animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists
acidophilus CUL-60 and CUL-21, L
Phase I breaks it down into metabolites, some of which are reactive and potentially harmful
Patients who commit fully to the lifestyle factors that amplify tesamorelins effect, specifically adequate protein intake, resistance training, 7 to 8 hours of sleep, and avoidance of late-night eating and alcohol, see results at the higher end of the expected range